ADVB · Advanced Biomed Inc.
Substantial doubt about the company's ability to continue as a going concern.
“All of these factors raise substantial doubt about the ability of the Company to continue as a going concern. The consolidated financial statements for the financial years ended June 30, 2025 and 2024 have been prepared on a going concern basis and do not include any adjustments to reflect the possible future effects on the recoverability and classifications of assets or the amounts and classifications of liabilities that may result from the inability of the Company to continue as a going concern.”View the 10-Q filed May 15, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-27 | Pau Hung To |
10% Owner |
Other↓
Filing footnotes — Common Stock par vlaue $0.001 (Direct)
The shares reported were transferred in satisfaction of indebtedness of the Reporting Person in the aggregate principal amount of $480,000, of which 100,000 shares were transferred to Lu Yi and 76,225 shares to Zhao Jie. |
Common Stock par vlaue $0.001
|
76,225 |
| 2026-07-27 | Pau Hung To |
10% Owner |
Other↓
Filing footnotes — Common Stock par vlaue $0.001 (Direct)
The shares reported were transferred in satisfaction of indebtedness of the Reporting Person in the aggregate principal amount of $480,000, of which 100,000 shares were transferred to Lu Yi and 76,225 shares to Zhao Jie. |
Common Stock par vlaue $0.001
|
100,000 |